Walleye Capital
IVP

Walleye Capital’s Inspire Veterinary Partners IVP Stock Holding History

Walleye Capital’s Portfolio IVP Stock Details IVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18
Closed -$60.1K – 5221
2023
Q3 		$60.1K Buy
+18
New +$85.9K ﹤0.01% 4139

Other funds holding IVP

HWM
Hohimer Wealth Management Seattle, Washington $847M AUM 29.89% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return
EWM
Executive Wealth Management Brighton, Michigan $1.28B AUM 16.54% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Walleye Capital's IVP Position: Q4 2023 in Review

Walleye Capital sold out of Inspire Veterinary Partners (IVP) in Q4 2023, closing a stake of 18 shares — an estimated $60.1K sold.

Walleye Capital first reported a position in IVP in Q3 2023 and held it in 1 quarter. The position peaked at $60.1K in Q3 2023. 8 funds tracked by Wall St. Rank hold IVP as of Q4 2023.

  • Walleye Capital reported no remaining Inspire Veterinary Partners position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 18 Inspire Veterinary Partners shares in Q4 2023, an estimated $60.1K.
  • Walleye Capital first reported a position in Inspire Veterinary Partners in Q3 2023 and held it in 1 quarter.
  • Walleye Capital's Inspire Veterinary Partners position peaked at $60.1K in Q3 2023.
  • 8 funds tracked by Wall St. Rank held Inspire Veterinary Partners as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.